Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Call Scheduled: August 21 at...
HONG KONG, Aug. 7, 2026 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) (the "Company" or "Metalpha"), through its subsidiaries, is a global leading provider...
The Singapore-headquartered distributor enters the region's top 10, following its No. 19 placement on the 2026 Top 50 Global Electronics Distributors List in May....